Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ABACAVIR\LAMIVUDINE Cause Product use issue? 235 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 235 reports of Product use issue have been filed in association with ABACAVIR\LAMIVUDINE. This represents 4.4% of all adverse event reports for ABACAVIR\LAMIVUDINE.

235
Reports of Product use issue with ABACAVIR\LAMIVUDINE
4.4%
of all ABACAVIR\LAMIVUDINE reports
87
Deaths
8
Hospitalizations

How Dangerous Is Product use issue From ABACAVIR\LAMIVUDINE?

Of the 235 reports, 87 (37.0%) resulted in death, 8 (3.4%) required hospitalization, and 5 (2.1%) were considered life-threatening.

Is Product use issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ABACAVIR\LAMIVUDINE. However, 235 reports have been filed with the FAERS database.

What Other Side Effects Does ABACAVIR\LAMIVUDINE Cause?

Exposure during pregnancy (593) Pyrexia (450) Rash (390) Foetal exposure during pregnancy (373) Hypertension (325) Headache (316) Hypersensitivity (289) Pain (271) Thrombocytopenia (271) Off label use (267)

What Other Drugs Cause Product use issue?

INFLIXIMAB (12,752) DUPILUMAB (10,575) POLYETHYLENE GLYCOL 3350 (9,432) METHOTREXATE (8,185) DICLOFENAC (8,009) RITUXIMAB (6,948) ADALIMUMAB (6,379) ETANERCEPT (6,062) TOCILIZUMAB (5,944) ABATACEPT (5,915)

Which ABACAVIR\LAMIVUDINE Alternatives Have Lower Product use issue Risk?

ABACAVIR\LAMIVUDINE vs ABACAVIR\LAMIVUDINE\ZIDOVUDINE ABACAVIR\LAMIVUDINE vs ABALOPARATIDE ABACAVIR\LAMIVUDINE vs ABATACEPT ABACAVIR\LAMIVUDINE vs ABATACEPT SUBQ /ML ABACAVIR\LAMIVUDINE vs ABCIXIMAB

Related Pages

ABACAVIR\LAMIVUDINE Full Profile All Product use issue Reports All Drugs Causing Product use issue ABACAVIR\LAMIVUDINE Demographics